Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by biotech1973on Oct 23, 2020 12:19pm
101 Views
Post# 31771166

I forgot to Mention

I forgot to Mention
They had 25 Million cash left during last quarter but they lost 10 Million in thr last quarter. Moreover they have 25 LOC sitting as well if they dont want to dilute. With Govt subsidies, they might have sufficient fund till March 5th. Having said that, they need money to start the commercialisation to prepare in advance. This is a big big gamble, either you loose 50% in 2 months or gain 500% in 6. Choice is yours. Faithfully your, Biotech
<< Previous
Bullboard Posts
Next >>